Acrivon Therapeutics, Inc. (ACRV)

Acrivon Therapeutics Statistics

Total Valuation

ACRV has a market cap or net worth of $74.47 million. The enterprise value is -$51.79 million.

Market Cap	74.47M
Enterprise Value	-51.79M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ACRV has 31.56 million shares outstanding. The number of shares has increased by 28.87% in one year.

Current Share Class	31.56M
Shares Outstanding	31.56M
Shares Change (YoY)	+28.87%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	7.96%
Owned by Institutions (%)	29.54%
Float	16.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.58
P/TBV Ratio	0.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.75, with a Debt / Equity ratio of 0.02.

Current Ratio	8.75
Quick Ratio	8.68
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.23% and return on invested capital (ROIC) is -33.44%.

Return on Equity (ROE)	-50.23%
Return on Assets (ROA)	-30.89%
Return on Invested Capital (ROIC)	-33.44%
Return on Capital Employed (ROCE)	-68.21%
Revenue Per Employee	n/a
Profits Per Employee	-$1.05M
Employee Count	78
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.04% in the last 52 weeks. The beta is 1.84, so ACRV's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	-67.04%
50-Day Moving Average	1.98
200-Day Moving Average	2.12
Relative Strength Index (RSI)	58.96
Average Volume (20 Days)	1,272,969

Short Selling Information

The latest short interest is 1.72 million, so 5.47% of the outstanding shares have been sold short.

Short Interest	1.72M
Short Previous Month	1.64M
Short % of Shares Out	5.47%
Short % of Float	10.23%
Short Ratio (days to cover)	4.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-88.95M
Pretax Income	-81.75M
Net Income	-81.75M
EBITDA	-87.65M
EBIT	-88.95M
Earnings Per Share (EPS)	-$2.13

Balance Sheet

The company has $129.25 million in cash and $2.99 million in debt, giving a net cash position of $126.27 million or $4.00 per share.

Cash & Cash Equivalents	129.25M
Total Debt	2.99M
Net Cash	126.27M
Net Cash Per Share	$4.00
Equity (Book Value)	128.60M
Book Value Per Share	4.08
Working Capital	115.47M

Cash Flow

In the last 12 months, operating cash flow was -$65.79 million and capital expenditures -$2.28 million, giving a free cash flow of -$68.07 million.

Operating Cash Flow	-65.79M
Capital Expenditures	-2.28M
Free Cash Flow	-68.07M
FCF Per Share	-$2.16

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACRV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.87%
Shareholder Yield	-28.87%
Earnings Yield	-109.78%
FCF Yield	-91.40%

Analyst Forecast

The average price target for ACRV is $14.67, which is 521.61% higher than the current price. The consensus rating is "Buy".

Price Target	$14.67
Price Target Difference	521.61%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-8.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1